Assessment of Blood-Brain Barrier Permeability in a Cerebral Ischemia-Reperfusion Model in Rats; A Pilot Study

P Kozler1, D Marešová, J Pokorný

  • 1Institute of Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic. jaroslav.pokorny@lf1.cuni.cz.

Physiological Research
|February 4, 2025
PubMed

Insights

The middle cerebral artery occlusion (MCAO) rodent model simulates human stroke with reperfusion. This study found the blood-brain barrier (BBB) becomes permeable to large molecules 120 minutes after MCAO, impacting stroke treatment strategies.

Area of Science:

  • Neuroscience
  • Cerebrovascular Research
  • Animal Models of Stroke

Background:

  • Stroke remains a leading cause of death and disability worldwide.
  • Animal models are crucial for understanding stroke pathophysiology and testing therapies.
  • The middle cerebral artery occlusion (MCAO) model in rodents closely mimics human ischemic stroke, including reperfusion.

Purpose of the Study:

  • To characterize the permeability of the blood-brain barrier (BBB) in a transient rodent MCAO model.
  • To determine the optimal timing for neuroprotective agent delivery following ischemic stroke.

Main Methods:

  • A transient middle cerebral artery occlusion (MCAO) model was established in rodents.
  • Ischemia was assessed using 2,3,5-triphenyltetrazolium chloride (TTC) staining.
  • Blood-brain barrier (BBB) permeability was evaluated using Evans blue (EB) dye distribution.

Main Results:

  • The study utilized 15 animals for the MCAO model and subsequent assessments.
  • Evans blue (EB) dye, a high molecular weight molecule, demonstrated significant brain entry.
  • BBB permeability was confirmed 120 minutes after the induction of ischemia, indicating opening to large molecules.

Conclusions:

  • The transient MCAO model effectively simulates cerebral ischemia-reperfusion relevant to human stroke.
  • The blood-brain barrier (BBB) opens approximately 120 minutes post-MCAO, allowing large molecules to enter the brain.
  • This finding is critical for timing the administration of neuroprotective agents via intra-arterial injection in future stroke research.

Related Concept Videos